We are live on
!
Find out more
Tenax Therapeutics
TENX
TENX
80 hedge funds and large institutions have $343M invested in Tenax Therapeutics in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,300% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 1
333% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 6
304% more capital invested
Capital invested by funds: $84.8M → $343M (+$258M)
67% more funds holding
Funds holding: 48 → 80 (+32)
13.47% more ownership
Funds ownership: 111.5% → 124.97% (+13%)
Holders
80
Holders Change
+32
Holders Change %
+66.67%
% of All Funds
0.98%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.05%
New
34
Increased
26
Reduced
6
Closed
1
Calls
$2.36M
Puts
–
Net Calls
+$2.36M
Net Calls Change
+$2.36M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$39.9M |
| 2 |
VA
VR Adviser
New York
|
+$22.7M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$22.3M |
| 4 |
PA
Perceptive Advisors
New York
|
+$13.6M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$13M |
Top Sellers
| 1 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$858K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$732K |
| 3 |
Corient Private Wealth
Miami,
Florida
|
-$168K |
| 4 |
RI
RTW Investments
New York
|
-$110K |
| 5 |
PAP
Persistent Asset Partners
Hong Kong
|
-$95.9K |
